Streetbeat News

Revenues

PINE

Alpine Income Prop Trust (NYSE:PINE) has been analyzed by 5 analysts, showing a range of ratings from bullish to indifferent. The average 12-month price target has increased by 6.42% to $19.05. Analysts have raised their ratings and price targets, indicating a positive outlook. Despite this, the company's revenue growth and net margin lag behind industry averages, though it has a strong ROE and conservative debt management.

Portfolio Pulse from Benzinga Insights

August 21, 2024 | 12:00 pm

SMFL

Smart for Life, Inc (NASDAQ:SMFL) is expanding its acquisition pipeline in the Health & Wellness sector, aiming for $100M in revenue. The company is negotiating acquisitions of four profitable targets and exploring additional prospects. SMFL's stock rose by 1.56% following the announcement.

Portfolio Pulse from Anusuya Lahiri

August 21, 2024 | 12:00 pm

ZK

Zeeker Intelligent Technology Holding shares rose following the release of their Q2 financial results, which exceeded expectations. The company also reported a year-over-year increase in Q2 deliveries.

Portfolio Pulse from Benzinga Newsdesk

August 21, 2024 | 11:42 am

TGT

Target Corporation (NYSE:TGT) reported strong Q2 earnings, surpassing expectations with a 40% increase in EPS and a 2.7% rise in sales. The company raised its full-year profit outlook, driven by growth in digital sales and same-day delivery services. Target's shares rose 12% premarket.

Portfolio Pulse from Nabaparna Bhattacharya

August 21, 2024 | 11:37 am

VVX

V2X has announced a significant task order from the US Army under the Warfighter-Training Readiness Solutions program, valued at $3.7 billion over five years. This contract highlights V2X's role in providing training solutions to the military.

Portfolio Pulse from Benzinga Newsdesk

August 21, 2024 | 11:31 am

CAH

Cardinal Health has announced plans to open a new distribution center in Walton Hills, Ohio, to support its U.S. Medical Products and Distribution business.

Portfolio Pulse from Benzinga Newsdesk

August 21, 2024 | 11:31 am

RDHL

Redhill Biopharma has launched Talicia in the UAE, marking its availability for treating H. pylori infections. This launch could lead to milestone payments and royalties for Redhill.

Portfolio Pulse from Benzinga Newsdesk

August 21, 2024 | 11:25 am

CMMB

Chemomab has announced that its liquidity resources of $12.8 million as of June 30, 2024, combined with an additional $10 million raised in July 2024, will support its operations until early 2026.

Portfolio Pulse from Benzinga Newsdesk

August 21, 2024 | 11:09 am

GDS

GDS Holdings reaffirms its FY24 guidance, projecting total revenues between RMB11,340 and RMB11,760 million, Adjusted EBITDA of RMB4,950 to RMB5,150 million, and capital expenditures of approximately RMB6,500 million. The company emphasizes alignment with growth initiatives to deliver long-term value.

Portfolio Pulse from Benzinga Newsdesk

August 21, 2024 | 11:06 am

ADI

Analog Devices has provided its Q4 fiscal 2024 guidance, forecasting adjusted EPS between $1.53 and $1.73, compared to the estimated $1.62. Revenue is expected to be between $2.3 billion and $2.5 billion, against an estimate of $2.38 billion. The company anticipates a reported operating margin of approximately 22.3% and an adjusted operating margin of about 41.0%.

Portfolio Pulse from Benzinga Newsdesk

August 21, 2024 | 11:05 am